These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 10960192)

  • 1. Synthesis and pharmacological evaluation of 2, 3-dihydro-3-oxo-4H-thieno[3,4-e][1,2,4]thiadiazine 1,1-dioxides as voltage-dependent calcium channel blockers.
    Arranz E; Díaz JA; Vega S; Campos-Toimil M; Orallo F; Cardelús I; Llenas J; Fernández AG
    Eur J Med Chem; 2000; 35(7-8):751-9. PubMed ID: 10960192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 3-Alkylamino-4H-pyrido[2,3-e]-1,2,4-thiadiazine 1,1-dioxides structurally related to diazoxide and pinacidil as potassium channel openers acting on vascular smooth muscle cells: design, synthesis, and pharmacological evaluation.
    Pirotte B; Ouedraogo R; de Tullio P; Khelili S; Somers F; Boverie S; Dupont L; Fontaine J; Damas J; Lebrun P
    J Med Chem; 2000 Apr; 43(8):1456-66. PubMed ID: 10780901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enantioselective synthesis and pharmacological evaluation of a new type of verapamil analog with hypotensive and calcium antagonist activities.
    Holland HL; Gu JX; Orallo F; Camiña M; Fabeiro P; Willetts AJ
    Pharm Res; 1999 Feb; 16(2):281-7. PubMed ID: 10100315
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 2-alkyl-3-Alkylamino-2H-Benzo- and pyridothiadiazine 1,1-dioxides: from K+ATP channel openers to Ca++ channel blockers?
    Ouedraogo R; Becker B; Boverie S; Somers F; Antoine MH; Pirotte B; Lebrun P; de Tullio P
    Biol Chem; 2002 Nov; 383(11):1759-68. PubMed ID: 12530541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and pharmacological evaluation of 4H-1,4-benzothiazine-2-carbonitrile 1,1-dioxide and N-(2-cyanomethylsulfonylphenyl)acylamide derivatives as potential activators of ATP sensitive potassium channels.
    Schou SC; Hansen HC; Tagmose TM; Boonen HC; Worsaae A; Drabowski M; Wahl P; Arkhammar PO; Bodvarsdottir T; Antoine MH; Lebrun P; Hansen JB
    Bioorg Med Chem; 2005 Jan; 13(1):141-55. PubMed ID: 15582459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies on the chemistry of thienoannelated O,N- and S,N-containing heterocycles. Part 19: thieno[2,3-b][1,4]thiazines with calcium antagonistic and potassium opening activities.
    Erker T; Schreder ME; Studenik C
    Arch Pharm (Weinheim); 2000 Mar; 333(2-3):58-62. PubMed ID: 10783519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 3-and 4-substituted 4H-pyrido[4,3-e]-1,2,4-thiadiazine 1,1-dioxides as potassium channel openers: synthesis, pharmacological evaluation, and structure-activity relationships.
    de Tullio P; Pirotte B; Lebrun P; Fontaine J; Dupont L; Antoine MH; Ouedraogo R; Khelili S; Maggetto C; Masereel B; Diouf O; Podona T; Delarge J
    J Med Chem; 1996 Feb; 39(4):937-48. PubMed ID: 8632417
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 4H-1,2,4-Pyridothiadiazine 1,1-dioxides and 2,3-dihydro-4H-1,2, 4-pyridothiadiazine 1,1-dioxides chemically related to diazoxide and cyclothiazide as powerful positive allosteric modulators of (R/S)-2-amino-3-(3-hydroxy-5-methylisoxazol-4-yl)propionic acid receptors: design, synthesis, pharmacology, and structure-activity relationships.
    Pirotte B; Podona T; Diouf O; de Tullio P; Lebrun P; Dupont L; Somers F; Delarge J; Morain P; Lestage P; Lepagnol J; Spedding M
    J Med Chem; 1998 Jul; 41(16):2946-59. PubMed ID: 9685234
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of the effects of the calcium entry blockers, verapamil, diltiazem and flunarizine against contractions of the rat isolated aorta and portal vein.
    Marriott JF
    Br J Pharmacol; 1988 Sep; 95(1):145-54. PubMed ID: 3219471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel tacrine derivatives that block neuronal calcium channels.
    de los Ríos C; Marco JL; Carreiras MD; Chinchón PM; García AG; Villarroya M
    Bioorg Med Chem; 2002 Jun; 10(6):2077-88. PubMed ID: 11937366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pyrrolo[2,1-c][1,4]benzothiazines: synthesis, structure-activity relationships, molecular modeling studies, and cardiovascular activity.
    Campiani G; Garofalo A; Fiorini I; Botta M; Nacci V; Tafi A; Chiarini A; Budriesi R; Bruni G; Romeo MR
    J Med Chem; 1995 Oct; 38(22):4393-410. PubMed ID: 7473567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structurally novel antihypertensive compound, McN-5691, is a calcium channel blocker in vascular smooth muscle.
    Flaim SF; Gleason MM; Hedberg A; Shank RP; McCullough JR; Gill A; Damiano BP; Brannan MD; Carson JR
    J Pharmacol Exp Ther; 1991 Jan; 256(1):279-88. PubMed ID: 1846419
    [TBL] [Abstract][Full Text] [Related]  

  • 13. L-Type calcium channel blockers: from diltiazem to 1,2,4-oxadiazol-5-ones via thiazinooxadiazol-3-one derivatives.
    Budriesi R; Cosimelli B; Ioan P; Ugenti MP; Carosati E; Frosini M; Fusi F; Spisani R; Saponara S; Cruciani G; Novellino E; Spinelli D; Chiarini A
    J Med Chem; 2009 Apr; 52(8):2352-62. PubMed ID: 19323482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SR 33557, a novel calcium entry blocker. I. In vitro isolated tissue studies.
    Polster P; Christophe B; Van Damme M; Houlliche A; Chatelain P
    J Pharmacol Exp Ther; 1990 Nov; 255(2):593-9. PubMed ID: 1700816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased function of voltage-dependent Ca++ channels and Ca(++)-activated K+ channels in resting state of femoral arteries from spontaneously hypertensive rats at prehypertensive stage.
    Asano M; Nomura Y; Ito K; Uyama Y; Imaizumi Y; Watanabe M
    J Pharmacol Exp Ther; 1995 Nov; 275(2):775-83. PubMed ID: 7473166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and Ca2+ antagonistic activity of 2-[2-[(aminoalkyl)oxy]-5-methoxyphenyl]-3,4-dihydro-4-methyl-3-oxo-2H- 1,4-benzothiazines.
    Fujita M; Ito S; Ota A; Kato N; Yamamoto K; Kawashima Y; Yamauchi H; Iwao J
    J Med Chem; 1990 Jul; 33(7):1898-905. PubMed ID: 2362267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of the nature of the substituent at the 3-position of 4H-1,2,4-benzothiadiazine 1,1-dioxides on their opening activity toward ATP-sensitive potassium channels.
    Pirotte B; de Tullio P; Boverie S; Michaux C; Lebrun P
    J Med Chem; 2011 May; 54(9):3188-99. PubMed ID: 21428460
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and biological activities of new 1,4-benzothiazine derivatives.
    Kajino M; Mizuno K; Tawada H; Shibouta Y; Nishikawa K; Meguro K
    Chem Pharm Bull (Tokyo); 1991 Nov; 39(11):2888-95. PubMed ID: 1799937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and biological activity of two new calcium-channel blockers, mebudipine and dibudipine.
    Mahmoudian M; Mirkhani H; Nehardani Z; Ghiaee S
    J Pharm Pharmacol; 1997 Dec; 49(12):1229-33. PubMed ID: 9466348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of aranidipine, a novel calcium channel blocker, on mechanical responses of the isolated rat portal vein: comparison with typical calcium channel blockers and potassium channel openers.
    Okumura K; Ichihara K; Nagasaka M
    J Cardiovasc Pharmacol; 1997 Feb; 29(2):209-15. PubMed ID: 9057070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.